4-6%
Annual dividend growth
guidance through 2030
7.0%
5-Year Rate Base CAGR
$28.8B
2026-2030 Capital Plan

Annual dividend growth
guidance through 2030
5-Year Rate Base CAGR
2026-2030 Capital Plan
(1) On November 3, 2025, Fortis declared a quarterly dividend of $0.64 per common share payable on December 1, 2025, marking its 52nd year of consecutive dividend increases.
Fortis has nine regulated utilities in Canada, the U.S., and the Caribbean.
Our 9,600 employees serve 3.5 million electricity and natural gas customers.
Our sustainable regulated growth strategy is focused on delivering cleaner energy that remains affordable and reliable for our customers while supporting annual dividend growth of 4-6% through 2030.
Safe, Well-Run Utilities
Strong Governance
Regulatory & Geographic Diversity
Constructive Regulatory Relationships
Local Business Model
100% Regulated
Primarily Transmission & Distribution Assets

Focused on Execution
Strong Rate Base Growth
Robust Transmission Investment Pipeline
Transparent Funding Plan
Cleaner Energy Transition
4-6% Annual Dividend Growth Through 2030
Investment-Grade Credit Ratings

Fortis has yielded a total annualized shareholder return of 9.5% over 20 years, or 513% in total.

| 1-Year | 19.3% |
| 5-Year | 9.5% |
| 10-Year | 10.5% |
| 20-Year | 9.5% |
As at September 30, 2025


| $ millions, except as indicated | 2024 | 2023 | Variance |
|---|---|---|---|
| Common Equity Earnings | |||
| Actual | 1,606 | 1,506 | 100 |
| Adjusted (1) | 1,626 | 1,502 | 124 |
| Basic EPS ($) | |||
| Actual | 3.24 | 3.10 | 0.14 |
| Adjusted (1) | 3.28 | 3.09 | 0.19 |
| Dividends | |||
| Paid per common share ($) | 2.39 | 2.29 | 0.10 |
| Actual Payout Ratio (%) | 73.6 | 73.7 | (0.1) |
| Adjusted Payout Ratio (%) (1) | 72.7 | 73.9 | (1.2) |
| Weighted average number of common shares outstanding (# millions) | 495 | 486.3 | 8.7 |
| Operating Cash Flow | 3,882 | 3,545 | 337 |
| Capital expenditures (1) | 5,247 | 4,329 | 918 |
(1) Non-GAAP financial measure as disclosed in the Corporation's Annual Management Discussion and Analysis